Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study.
Victor J M ZeijenDominic A M J TheunsJoost DaemenKari A SavilleRohit E BhagwandienIsabella KardysNicolas M D A van MieghemJoost DaemenPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
In patients with hypertension and symptomatic AF, stand-alone RDN reduced BP but did not significantly reduce AF burden up until 3 years of follow-up.